Personally and my medical knowledge stops at band-aid application, I reckon the newsletter reads pretty solid, but ANP remains a long-term play. In the current market, nothing short of a big deal done will drive any share up! ANP is my next MSB, which I believe in turn will be the next CSL - there my big UNprofessional calls, but you gotta have faith and a long-time horizon!
DYOR.
;)
antisense technology, page-15
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
